Independent Director · Intellia Therapeutics, Inc. (NTLA)

Brian Goff — Intellia Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Brian Goff at Intellia Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Intellia Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Intellia Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$63,740$66,960$65,740—$196,440

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Intellia Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-197283, and prior-year filings. Open the filing on EDGAR.

The rest of the Intellia Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Frank VerwielIndependent Director$232,700
William ChaseIndependent Director$205,200

The full Intellia Therapeutics compensation record

free company brief

This page is one director within Intellia Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy